News

American Association of Individual Investors7d
Why Compass Therapeutics, Inc.’s (CMPX) Stock Is Down 24.55%
Compass Therapeutics, Inc.’s CMPX share price has dipped by 24.55%, which has investors questioning if this is right time to ...
technologynetworks1y
Biopharma Compass: Next Generation Therapeutic Protein Characterization By Mass Spectrometry
Mass Spectrometry is an increasingly important tool to support the development of therapeutic proteins. This means laboratories need ... to a more „open access“ like experience. BioPharma Compass was ...
American Association of Individual Investors8d
Why Compass Therapeutics, Inc.’s (CMPX) Stock Is Up 17.89%
Compass Therapeutics, Inc.’s CMPX share price has surged by 17.89%, which has investors questioning if this is right time to sell.